Barclays Starts Abbvie (ABBV) at Equalweight

Go back to Barclays Starts Abbvie (ABBV) at Equalweight

Deutsche Bank Downgrades Abbott Labs (ABT) to Hold to Reflect 'new ABT'

January 4, 2013 7:09 AM EST

Deutsche Bank downgraded Abbott Labs (NYSE: ABT) from Buy to Hold with a price target of $33.00 (from $70.00) following real-way trading of newly spun AbbVie (NYSE: ABBV)

The firm comments, "With this note, we are establishing our... More

BofA/Merrill Lynch Starts Abbvie (ABBV) at Buy

January 4, 2013 6:44 AM EST

BofA/Merrill Lynch initiates coverage on Abbvie (NYSE: ABBV) with a Buy. PT $40.00.

For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.

Shares of Abbvie closed at $34.83 yesterday, with a 52 week range of $34.10-$35.40.... More

JPMorgan Starts Abbvie (ABBV) at Overweight

January 2, 2013 7:36 AM EST

JPMorgan initiates coverage on Abbvie (NYSE: ABBV) with a Overweight. PT $38.00.

For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.

Shares of Abbvie closed at $ yesterday, with a 52 week range of $-$.... More

BMO Capital Starts Abbvie (ABBV) at Outperform

January 2, 2013 7:36 AM EST

BMO Capital initiates coverage on Abbvie (NYSE: ABBV) with a Outperform. PT $39.00.

For an analyst ratings summary and ratings history on Abbvie click here. For more ratings news on Abbvie click here.

Shares of Abbvie closed at $ yesterday, with a 52 week range of $-$.... More